Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
3M Reaches $10.3 Billion Settlement
3M Co. reached a $10.3 billion agreement to settle lawsuits that claimed toxic chemicals had contaminated drinking water across the country.
Load More